Ellen Dukes

7.7k total citations · 1 hit paper
55 papers, 6.0k citations indexed

About

Ellen Dukes is a scholar working on Physiology, Pharmacology and Neurology. According to data from OpenAlex, Ellen Dukes has authored 55 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 24 papers in Pharmacology and 22 papers in Neurology. Recurrent topics in Ellen Dukes's work include Pain Mechanisms and Treatments (30 papers), Musculoskeletal pain and rehabilitation (23 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Ellen Dukes is often cited by papers focused on Pain Mechanisms and Treatments (30 papers), Musculoskeletal pain and rehabilitation (23 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Ellen Dukes collaborates with scholars based in United States, Germany and United Kingdom. Ellen Dukes's co-authors include Margaret C. Reilly, Arthur S. Zbrozek, Gerry Oster, Deborah L. Hoffman, Ariel Berger, Alesia Sadosky, Mugdha Gore, Nancy A. Brandenburg, John Edelsberg and Hans‐Ulrich Wïttchen and has published in prestigious journals such as Pain, Neurosurgery and Age and Ageing.

In The Last Decade

Ellen Dukes

55 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

1993 2.3k citations Ellen Dukes et al. profile →

Peers

Countries citing papers authored by Ellen Dukes

Since Specialization

Citations

This map shows the geographic impact of Ellen Dukes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Dukes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Dukes more than expected).

Fields of papers citing papers by Ellen Dukes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Dukes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Dukes. The network helps show where Ellen Dukes may publish in the future.

Co-authorship network of co-authors of Ellen Dukes

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Dukes. A scholar is included among the top collaborators of Ellen Dukes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Dukes. Ellen Dukes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study 2012 ·BMC Neurology ·Ariel Berger, Alesia Sadosky, Ellen Dukes, John Edelsberg, Gerry Oster	47
2	Characteristics of patients with fibromyalgia in France and Germany 2010 ·International Journal of Clinical Practice ·Serge Perrot, Andreas Winkelmann, Ellen Dukes, Xiao Xu, Caroline Schaefer, Kellie Ryan, Arthi Chandran, Alesia Sadosky, Gergana Zlateva	33
3	Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective 2009 ·The European Journal of Health Economics ·Montserrat Vera‐Llonch, Ellen Dukes, Javier Rejas, Oleg Sofrygin, Marko A. Mychaskiw, Gerry Oster	19
4	Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia 2009 ·Health and Quality of Life Outcomes ·Alesia Sadosky, Ellen Dukes, (unknown)	15
5	Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder 2009 ·BMC Geriatrics ·Ariel Berger, Marko A. Mychaskiw, Ellen Dukes, John Edelsberg, Gerry Oster	13
6	[Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam]. 2008 ·PubMed ·Silvia Díaz‐Cerezo, (unknown), J.F. Horga, Montserrat Vera‐Llonch, Ellen Dukes, Javier Rejas	1
7	Use of Pregabalin in Patients with Painful Neuropathic Disorders under the Care of General Practitioners in the U.K. 2008 ·Pain Practice ·Ariel Berger, Alesia Sadosky, Ellen Dukes, John Edelsberg, Gerry Oster	6
8	Characteristics and healthcare costs of patients with fibromyalgia syndrome 2007 ·International Journal of Clinical Practice ·Ariel Berger, Ellen Dukes, Susan Martin, John Edelsberg, Gerry Oster	256
9	Use of Tricyclic Antidepressants in Older Patients With Diabetic Peripheral Neuropathy 2007 ·Clinical Journal of Pain ·Ariel Berger, Ellen Dukes, John Edelsberg, Brett R. Stacey, Gerry Oster	26
10	The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12 2007 ·International Journal of Clinical Practice ·(unknown), Ellen Dukes	224
11	Use of tricyclic antidepressants in older patients with painful neuropathies 2006 ·European Journal of Clinical Pharmacology ·Ariel Berger, Ellen Dukes, John Edelsberg, Brett R. Stacey, Gerry Oster	14
12	Human and economic burden of generalized anxiety disorder 2006 ·Depression and Anxiety ·Deborah L. Hoffman, Ellen Dukes, Hans‐Ulrich Wïttchen	333
13	Analgesic outcomes in patients with painful diabetic neuropathy or post-herpetic neuralgia receiving pregabalin versus gabapentin 2005 ·Journal of Pain ·Montserrat Vera‐Llonch, Ellen Dukes, Charles E. Argoff, Gerry Oster	3
14	Treatment of peripheral neuropathic pain: A simulation model 2005 ·European Journal of Pain ·Montserrat Vera‐Llonch, Ellen Dukes, Thomas E. Delea, (unknown), Gerry Oster, (unknown)	9
15	Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy 2005 ·Pain ·Diane C. Zelman, Ellen Dukes, Nancy A. Brandenburg, Alan Bostrom, Mugdha Gore	200
16	Acceptable, manageable, and tolerable days: patient daily goals for medication management of persistent pain 2004 ·Journal of Pain and Symptom Management ·Diane C. Zelman, Meredith Y. Smith, (unknown), (unknown), (unknown), Ellen G. Levine, (unknown), Ellen Dukes	19
17	Clinical outcomes measurement 2004 ·Journal of Pain ·(unknown), Nancy A. Brandenburg, Ellen Dukes, (unknown), (unknown), K. Tai	3
18	Clinical characteristics and economic costs of patients with painful neuropathic disorders 2004 ·Journal of Pain ·Ariel Berger, Ellen Dukes, Gerry Oster	288
19	Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia 2003 ·Clinical Therapeutics ·Ariel Berger, Ellen Dukes, Bill McCarberg, (unknown), Gerry Oster	15
20	Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life 2003 ·Journal of Pain and Symptom Management ·Ariel Berger, Ellen Dukes, Meredith Y. Smith, May Hagiwara, Raafat Seifeldin, Gerry Oster	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact